NEUROCRINE BIOSCIENCES INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Neurocrine Biosciences Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Neurocrine Biosciences Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $263M, a 215% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $263M +$179M +215% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $271M +$186M +221% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $277M +$190M +218% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $80.8M -$8.8M -9.82% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $83.5M -$8.7M -9.44% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $84.4M -$10.3M -10.9% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $87M -$10.2M -10.5% Dec 31, 2022 10-K 2024-02-09
Q3 2022 $89.6M -$8.3M -8.48% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $92.2M -$8.1M -8.08% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $94.7M -$2.3M -2.37% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $97.2M +$14.4M +17.4% Dec 31, 2021 10-K 2023-02-09
Q3 2021 $97.9M +$26.9M +37.9% Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $100M +$28.2M +39.1% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $97M +$23.7M +32.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $82.8M +$8.5M +11.4% Dec 31, 2020 10-K 2022-02-11
Q3 2020 $71M +$9.01M +14.5% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $72.1M +$23M +46.9% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 $73.3M +$24M +48.7% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $74.3M +$74.3M Dec 31, 2019 10-K 2021-02-05
Q3 2019 $62M Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $49.1M Jun 30, 2019 10-Q 2019-07-29
Q1 2019 $49.3M Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $0 Dec 31, 2018 10-Q 2019-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.